FY2020 NIH awards · Principal investigators

Pharmacology at Thomas Jefferson University

Philadelphia, PA

Funding

$2M

$1,994,501

Awards

7

FY2020 NIH awards in Pharmacology

Principal investigators

5

5 lead a grant here, 0 co-investigators

Department rank

#94

of 142 · Ranking

NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
These are the awards in the Pharmacology row of the Thomas Jefferson University page.

Leads a grant in this department

5 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

Kraft, Walter K
Leads 1 award · $774,341
- 2T32GM008562-26Department: NIH department code
  Clinical Pharmacology Training Program
  $774,341
  award amount
Waldman, Scott A
Leads 2 awards · $714,820
- 5R01CA204481-04Department: NIH department code
  Guanylin GUCY2C axis in Colorectal Cancer Initiation
  $357,970
  award amount
- 5R01CA206026-05Department: NIH department code
  (PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
  $356,850
  award amount
Chervoneva, Inna
Leads 2 awards · $436,232
- 5R01CA222847-02Department: NIH department code
  Statistical Methods For Quantitative Immunohistochemistry Biomarkers
  $355,385
  award amount
- 5R03HD098476-02Department: NIH department code
  Development of the simplified Neonatal Abstinence Syndrome Scoring System
  $80,847
  award amount
Rappaport, Jeffrey
Leads 1 award · $46,788
- 5F30CA232469-02Department: NIH department code
  Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer
  $46,788
  award amount
Pattison, Amanda
Leads 1 award · $22,320
- 5F31CA225123-03Department: NIH department code
  Reactivating the GUCY2C signaling axis opposes oncogenic B-catenin for cancer chemoprevention
  $22,320
  award amount